NEW YORK (GenomeWeb News) - Qiagen announced last night that it has opened a new service solutions center in Singapore to serve the entire Asia-Pacific region.
The facility joins the firm’s six existing centers in the US, Europe, and Japan.
Qiagen said that the new center will help it serve customers in the research, applied testing, pharmaceutical, and molecular diagnostics markets in the entire Asia-Pacific region including Australia. The facility also will provide customer care and technical service requests in regional languages including Korean, Mandarin, Cantonese, Malay, and English.
"With this investment we can better respond to the needs of each and every customer, and we can also extend our services to 24 hours a day, 7 days a week in the near future,” Qiagen CEO Peer M. Schatz said in a statement.
Qiagen recently expanded its operations in Singapore through the creation of Dx Assay, a molecular diagnostics joint venture with Bio*One Capital. The venture will collaborate with all of Qiagen’s development facilities, including Digene’s operations, in developing new assays.
Qiagen currently employs more than 50 staffers in Singapore.